Sinobioway Group
2
18M
2
0.07
1
- Areas of investment
Summary
Sinobioway Group appeared to be the Corporate Investor, which was created in 1992. The fund was located in Asia if to be more exact in China. The main department of described Corporate Investor is located in the Haidian.
The high activity for fund was in 2018. The fund is generally included in less than 2 deals every year.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the Sinobioway Group, startups are often financed by The Westly Group, Braemar Energy Ventures, Waste Management. The meaningful sponsors for the fund in investment in the same round are Waste Management, The Westly Group, Rho Capital Partners. In the next rounds fund is usually obtained by The Westly Group, Sunkem, Suncor Energy.
Among the most popular fund investment industries, there are Waste Management, CleanTech. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular portfolio startups of the fund, we may highlight Enerkem. Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Rounds per year
- 0.07
- Investments by industry
- Biofuel (1)
- CleanTech (1)
- Energy Production (1)
- Waste Management (1)
- Environmental Services (B2B) (1) Show 6 more
- Investments by region
-
- Canada (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Exuma Biotech | 16 Feb 2017 | Biotechnology, Health Care, Big Data, Medical | Early Stage Venture | 37M |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.